Leiomyoma
📧 Sign up to get email alerts when something new happens for Leiomyoma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-20EMA Authorised: Ryeqo (relugolix;norethisterone acetate;estradiol hemihydrate) — Gedeon Richter Plc.
EMA authorized Ryeqo for leiomyoma, with relugolix combined with norethisterone acetate and estradiol hemihydrate, by Gedeon Richter Plc.
-
EMA approval · 2024-02-23EMA Authorised: Ryeqo (relugolix;norethisterone acetate;estradiol hemihydrate) — Gedeon Richter Plc.
EMA authorised Ryeqo, a combination therapy for leiomyoma, developed by Gedeon Richter Plc.